A Comprehensive Assessment of the Utility of Transperineal Template Mapping Biopsy: A Thirteen Year Experience.

[1]  T. Hermanns,et al.  Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy , 2021, The Prostate.

[2]  F. Fraggetta,et al.  Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted Cores. , 2021, Clinical genitourinary cancer.

[3]  U. Nagele,et al.  Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis. , 2020, Turkish journal of urology.

[4]  M. Frydenberg,et al.  Predictors of erectile dysfunction after transperineal template prostate biopsy , 2020, Investigative and clinical urology.

[5]  P. Choyke,et al.  MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. , 2020, The New England journal of medicine.

[6]  F. Fraggetta,et al.  How many cores should be obtained during saturation biopsy in the era of multiparametric magnetic resonance? Experience in 875 patients submitted to repeat prostate biopsy. , 2019, Urology.

[7]  Minyong Kang,et al.  Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy , 2019, Urologia Internationalis.

[8]  Xiangyi Zheng,et al.  Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis , 2019, World Journal of Surgical Oncology.

[9]  J. Xu,et al.  [Complications of transperineal template-guided prostate mapping biopsy]. , 2019, Zhonghua yi xue za zhi.

[10]  W. Butler,et al.  Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy , 2016, American journal of clinical oncology.

[11]  P. Carroll,et al.  Prostate Cancer Early Detection, Version 2.2015 , 2015 .

[12]  J. Ferlay,et al.  Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. , 2015, European journal of cancer.

[13]  T. Polascik,et al.  Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy. , 2013, Urology.

[14]  W. Butler,et al.  Transperineal Template-guided Mapping Biopsy as a Staging Procedure to Select Patients Best Suited for Active Surveillance , 2013, American journal of clinical oncology.

[15]  B. Helfand,et al.  The Impact of Prostate Biopsy on Urinary Symptoms, Erectile Function, and Anxiety , 2012, Current Urology Reports.

[16]  Yipeng Hu,et al.  Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.

[17]  E. Crawford,et al.  The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. , 2011, The Journal of urology.

[18]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[19]  J. Moul,et al.  Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. , 2008, Urology.

[20]  G. Onik,et al.  Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. , 2008, Urologic oncology.

[21]  K. Wallner,et al.  The morbidity of transperineal template‐guided prostate mapping biopsy , 2008, BJU international.

[22]  A. Henderson,et al.  Extensive transperineal template biopsies of prostate: modified technique and results. , 2006, Urology.

[23]  B. Moran,et al.  Re-biopsy of the prostate using a stereotactic transperineal technique. , 2006, The Journal of urology.

[24]  Holly T. Sullivan,et al.  Clinical staging of prostate cancer: a computer‐simulated study of transperineal prostate biopsy , 2005, BJU international.

[25]  Paul R Young,et al.  Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. , 2005, Urology.

[26]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[27]  T. Wheeler,et al.  Predictors of prostate cancer after initial negative systematic 12 core biopsy. , 2004, The Journal of urology.

[28]  S B Malkowicz,et al.  Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. , 2001, The Journal of urology.

[29]  W. Fair,et al.  Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998 .